Welcome to our dedicated page for JANUS LIVING news (Ticker: JAN), a resource for investors and traders seeking the latest updates and insights on JANUS LIVING stock.
The news page for JanOne Inc. (historically Nasdaq: JAN) provides an archive of company announcements and press releases that document its transition into ALT5 Sigma Corporation and the evolution of its business focus. These news items explain how the organization moved from being described primarily as a biopharmaceutical company focused on non-addicting pain treatments to a multidisciplinary entity combining healthcare initiatives with a growing fintech platform centered on blockchain-powered digital asset services.
Readers will find coverage of the company’s confirmation of its name change to ALT5 Sigma Corporation and ticker change to ALTS, reflecting a strategic realignment to focus on its recently acquired ALT5 Sigma fintech business as a core engine for revenue growth. News articles describe the acquisition and integration of ALT5 Sigma Inc., the company’s addition to the Russell Microcap Index, and subsequent developments such as the launch of the ALT5 Settlement Platform, the introduction of a prepaid Visa card integration, and reported transaction volumes processed by ALT5 subsidiaries.
The archive also includes updates on leadership appointments related to the fintech business, such as the naming of a Chief Revenue Officer and President for ALT5 Sigma, as well as communications about the company’s ongoing biotech activities aimed at addressing the opioid crisis. Earlier releases highlight JanOne’s efforts to develop non-addicting pain treatments and its dedication to funding innovation, technology, and education in this area.
By reviewing the JAN news feed, investors and researchers can trace key milestones, including the acquisition of ALT5 Sigma, strategic realignment decisions, and subsequent product and platform launches in digital payments and digital asset trading. Because the active Nasdaq ticker has changed from JAN to ALTS, this page serves as a historical record of announcements made under the JAN symbol, complementing more recent disclosures filed under the ALT5 Sigma Corporation identity.
Janus Living (NYSE: JAN) closed a new unsecured Credit Facility totaling $600 million, comprising a $500 million unsecured revolving facility (maturing March 2030 with two six-month extensions) and a $100 million unsecured delayed-draw term loan (maturing March 2031).
Borrowings carry interest at SOFR plus 105–110 bps based on leverage pricing. The Credit Facility was undrawn at closing and increases total liquidity to approximately $1.5 billion as of March 23, 2026. The company expects to use liquidity for future growth and general corporate purposes.
Healthpeak Properties (NYSE: DOC) and Janus Living (NYSE: JAN) announced that Janus Living completed an initial public offering of 48,300,000 Class A-1 shares at $20.00 per share, including full exercise of a 6,300,000-share underwriter option. Shares began trading on March 20, 2026 under JAN.
Net proceeds were approximately $878 million, to be used for acquisitions, investments meeting Janus Living’s criteria and general corporate purposes. Lead book-runners were BofA Securities and J.P. Morgan.
Janus Living (NYSE: JAN) makes its public debut on March 20, 2026, beginning trading on the New York Stock Exchange with an on-site IPO celebration.
The NYSE pre-market update also notes market moves, a Guardian Metal Resources listing on NYSE American, and upcoming small‑cap conference activity.
Healthpeak Properties (NYSE:DOC) and Janus Living priced Janus Living’s upsized IPO of 42,000,000 Class A-1 shares at $20.00 per share, with a 30-day underwriter option for an additional 6,300,000 shares. Janus Living expects NYSE trading to begin on March 20, 2026 under ticker JAN, and closing is expected on March 23, 2026, subject to customary conditions.
After the IPO, Healthpeak will own approximately 214,734,000 Janus Living shares, representing an approximate 83.6% voting interest (81.6% if the option is fully exercised). Proceeds will be used for acquisitions, investments, and general corporate purposes.
JanOne Inc. (Nasdaq: JAN) announced a corporate rebranding to ALT5 Sigma , effective July 15, 2024. This includes a change in its Nasdaq ticker symbol from JAN to ALTS and a new website address, alt5sigma.com. These changes are part of a strategic shift to focus on fintech, particularly the ALT5 Sigma fintech platform, while maintaining its biotech initiatives. The company processed over $1.2 billion in cryptocurrency transactions in 2023 through its fintech platforms, ALT5 Pay and ALT5 Prime. Stockholders are not required to take any action with respect to these changes.
JanOne announced a strategic realignment focusing on ALT5 Sigma, a fintech acquired in May. The company plans to monetize its biotech assets through spin-offs, alliances, or sales. The board approved the name change to ALT5 Sigma and a ticker change to ALTS. This realignment aims to enhance stockholder value by capitalizing on ALT5's fintech potential, which includes blockchain-powered platforms like ALT5 Pay and ALT5 Prime. The biotech division will continue, with its innovative pain treatment patent, Jan123, remaining intact. Timing for these changes will be announced later.
JanOne (Nasdaq: JAN) has appointed Vay Tham as Chief Revenue Officer and President of its fintech subsidiary, ALT5 Sigma. Tham brings over 25 years of experience in capital markets, particularly in technology sectors, including his recent role as Managing Director and Head of Technology Investment Banking at PI Financial Corp. He will lead ALT5 Sigma's go-to-market strategy to expand its digital financial ecosystem. Tham has been granted 400,000 restricted stock units (RSUs) which will vest over two years. ALT5 Sigma, a fintech firm launched in 2018, processed over $1.2 billion in cryptocurrency transactions in 2023 through its platforms, ALT5 Pay and ALT5 Prime.
JanOne's subsidiary, ALT5 Sigma, has launched a prepaid VISA®️ Card as part of its ALT5 Settlement Platform to bridge traditional financial systems with the digital crypto realm. This card allows institutions and merchants to convert crypto to fiat seamlessly, providing instant access to funds via a physical or digital prepaid VISA®️ Card. This move aims to offer customers more efficient ways to access and spend fiat currency derived from their crypto activities. The card is available for multi-currency use, converting funds 24/7, enhancing the versatility and flexibility of their financial operations.
JanOne's subsidiary, ALT5 Sigma, reported a significant year-over-year increase in transaction volume for April and May 2024. The total volume reached $289 million, marking a 91% increase from the $151 million reported during the same period in 2023. The company attributes this growth to word-of-mouth and client referrals, and they are now expanding their global marketing efforts. According to President Andre Beauchesne, the rising adoption of cryptocurrencies across various industries is driving the demand for ALT5 Sigma's B2B solutions.
JanOne (Nasdaq: JAN) announced that its subsidiary, ALT5 Sigma, has introduced the ALT5 Settlement Platform targeting the $27.3 billion Global Digital Content Creation Market. The platform enables digital platforms to pay content creators instantly in cryptocurrencies like Bitcoin, Ether, USDT, and USDC, reducing remittance costs and speeding up the payment process. It also allows creators to load a prepaid VISA card with crypto funds, usable at over 130 million Visa merchant locations worldwide. Launched in September 2023, the platform's pilot saw settlement volumes grow from $1 million to $7 million per month.